Production (Stage)
Arcutis Biotherapeutics, Inc.
ARQT
$13.98
$0.322.34%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -13.10% | -31.04% | -8.79% | -10.26% | 48.56% |
| Total Receivables | 16.90% | 21.54% | 38.49% | 16.84% | 43.97% |
| Inventory | 14.37% | 3.65% | 0.97% | 4.78% | 0.86% |
| Prepaid Expenses | 30.32% | 29.71% | -19.13% | -11.11% | 30.53% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -5.57% | -16.39% | 203.33% | 410.37% | -93.53% |
| Total Current Assets | -3.62% | -20.74% | -2.50% | -7.15% | 41.65% |
|
|
|||||
| Total Current Assets | -3.62% | -20.74% | -2.50% | -7.15% | 41.65% |
| Net Property, Plant & Equipment | 11.49% | -7.76% | -7.52% | -3.39% | -6.85% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 74.07% | -3.20% | 61.50% | -2.99% | -2.92% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.17% | -0.17% | 0.00% |
| Total Assets | -1.37% | -20.23% | -1.66% | -7.06% | 40.18% |
|
|
|||||
| Total Accounts Payable | 72.50% | -26.42% | 143.30% | -38.75% | 8.15% |
| Total Accrued Expenses | -0.33% | 24.97% | 23.83% | 26.94% | -1.05% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.68% | -99.18% | 12,810.04% | 2.78% | 2.86% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 12.49% | -53.02% | 235.77% | 8.55% | 1.37% |
|
|
|||||
| Total Current Liabilities | 12.49% | -53.02% | 235.77% | 8.55% | 1.37% |
| Long-Term Debt | 0.39% | 2.01% | -48.43% | 0.50% | 0.50% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -8.67% | -7.58% | -6.92% | -6.38% | -5.94% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -36.84% | 35.71% | 116.49% | -36.60% | -63.96% |
| Total Liabilities | 5.28% | -31.84% | 8.66% | 1.87% | 0.36% |
|
|
|||||
| Common Stock & APIC | 0.81% | 0.96% | 0.87% | 1.13% | 16.05% |
| Retained Earnings | -2.23% | -0.97% | -3.88% | -5.14% | -3.60% |
| Treasury Stock & Other | -1,900.00% | -101.31% | 281.29% | -121.05% | -3,425.00% |
| Total Common Equity | -9.45% | 0.57% | -15.98% | -17.12% | 153.69% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.45% | 0.57% | -15.98% | -17.12% | 153.69% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.45% | 0.57% | -15.98% | -17.12% | 153.69% |
|
|
|||||